OVA Conjugated Human Kallikrein 13 (KLK13)
Selected Variant
RPU50893-01
Size: 50 µg
OVA Conjugated Human Kallikrein 13 (KLK13) is a purified Conjugated Small Molecules. Purity: >90% by SDS-PAGE. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens) . Target Name: Kallikrein 13 (KLK13) . Target Synonyms: KLK-L4; KLKL4; Kallikrein-like protein 4. Accession Number: Q9UKR3. Expression Region: Ile262~Gln277. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
OVA Conjugated Human Kallikrein 13 (KLK13) is a purified Conjugated Small Molecules.
Accession Number
Q9UKR3
Expression Region
Ile262~Gln277
Expression System
Protein Conjugation
Target
Kallikrein 13 (KLK13)
Conjugation
OVA
Applications
Immunogen, SDS-PAGE, WB
Field of Research
Enzyme, Kinase
Endotoxin
<1.0EU/ug, by the LAL method
Purity
>90% by SDS-PAGE
Activity
Not Tested
Format
Freeze-dried powder
Buffer
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
KLK-L4; KLKL4; Kallikrein-like protein 4
Species
Human (Homo sapiens)
Protein Name
Conjugated Small Molecules
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-TRMT61A Antibody Picoband®, PE Conjugate
Cytokeratin 10 (KRT10/844), CF405S conjugate, 0.1mg/mL
NME1 / nm23-H1 / NDPK-A (Suppressor of Metastasis) (CPTC-NME1-2), CF594 conjugate, 0.1mg/mL
Smooth Muscle Actin (1A4), CF568 conjugate, 0.1mg/mL
